Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 570

1.

Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.

Dietert RR.

J Immunotoxicol. 2008 Oct;5(4):401-12. doi: 10.1080/15476910802483324. Erratum in: J Immunotoxicol. 2009 Mar;6(1):74.

PMID:
19404874
2.

Recent progress and diverse effects in developmental immunotoxicology: overview of a symposium at the 46th Annual SOT Meeting, Charlotte, NC.

Rooney AA, Yang Y, Makris SL.

J Immunotoxicol. 2008 Oct;5(4):395-400. doi: 10.1080/15476910802481443. Erratum in: J Immunotoxicol. 2009 Mar;6(1):74.

PMID:
19404873
3.

Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia.

Dietert RR.

Blood Cells Mol Dis. 2009 Mar-Apr;42(2):108-12. doi: 10.1016/j.bcmd.2008.10.005. Epub 2008 Nov 20. Review.

PMID:
19019708
4.

Developmental immunotoxicology: focus on health risks.

Dietert RR.

Chem Res Toxicol. 2009 Jan;22(1):17-23. doi: 10.1021/tx800198m. Review.

PMID:
18783253
5.

Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.

Dietert RR, Dietert JM.

J Toxicol Environ Health B Crit Rev. 2008 Oct;11(8):660-80. doi: 10.1080/10937400802370923. Review.

PMID:
18821424
6.

The managed immune system: protecting the womb to delay the tomb.

Dietert RR, Piepenbrink MS.

Hum Exp Toxicol. 2008 Feb;27(2):129-34. doi: 10.1177/0960327108090753.

PMID:
18480137
7.

Methodologies for developmental immunotoxicity (DIT) testing.

Dietert RR, Holsapple MP.

Methods. 2007 Jan;41(1):123-31. Review.

PMID:
17161309
8.

Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.

Dietert RR, Dewitt J.

Methods Mol Biol. 2010;598:17-25. doi: 10.1007/978-1-60761-401-2_2.

PMID:
19967503
9.

Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.

Dietert RR.

Reprod Toxicol. 2011 Apr;31(3):319-26. doi: 10.1016/j.reprotox.2010.09.006. Epub 2010 Sep 18. Review.

PMID:
20854896
10.

Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma.

Dietert RR, Zelikoff JT.

Birth Defects Res B Dev Reprod Toxicol. 2008 Dec;83(6):547-60. doi: 10.1002/bdrb.20170. Review.

PMID:
19085948
11.
12.

Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME).

Dietert RR, Dietert JM.

Toxicology. 2008 May 2;247(1):61-72. doi: 10.1016/j.tox.2008.01.022. Epub 2008 Feb 8. Review.

PMID:
18336982
13.

Toxicopathology of the developing immune system: investigative and development strategies.

Weinstock D, Lewis DB, Parker GA, Beyer J, Collinge M, Brown TP, Dybdal N.

Toxicol Pathol. 2010 Dec;38(7):1111-7. doi: 10.1177/0192623310382436. Epub 2010 Oct 20.

PMID:
20962107
14.

Current status of developmental immunotoxicity: early-life patterns and testing.

DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR.

Toxicol Pathol. 2012;40(2):230-6. doi: 10.1177/0192623311427709. Epub 2011 Nov 22. Review.

PMID:
22109713
15.

Testing human biologicals in animal host resistance models.

Burleson GR, Burleson FG.

J Immunotoxicol. 2008 Jan;5(1):23-31. doi: 10.1080/15476910801897557. Review.

PMID:
18382855
17.

Maternal and early life stress effects on immune function: relevance to immunotoxicology.

Bellinger DL, Lubahn C, Lorton D.

J Immunotoxicol. 2008 Oct;5(4):419-44. doi: 10.1080/15476910802483415. Review. Erratum in: J Immunotoxicol. 2009 Mar;6(1):74. Retraction in: Cohen M, Roulleau J. J Immunotoxicol. 2011 Oct-Dec;8(4):399.

PMID:
19404876
18.

What's so special about the developing immune system?

Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP.

Int J Toxicol. 2008 Mar-Apr;27(2):223-54. doi: 10.1080/10915810801978110. Review.

PMID:
18404545
19.

Mechanisms of dimethylbenzanthracene-induced immunotoxicity.

Dean JH, Ward EC, Murray MJ, Lauer LD, House RV.

Clin Physiol Biochem. 1985;3(2-3):98-110.

PMID:
3924465
20.

Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.

Collinge M, Burns-Naas LA, Chellman GJ, Kawabata TT, Komocsar WJ, Piccotti JR, Shenton J, Wierda D.

J Immunotoxicol. 2012 Apr-Jun;9(2):210-30. doi: 10.3109/1547691X.2012.661486. Epub 2012 Mar 19. Review.

PMID:
22428536

Supplemental Content

Support Center